NeoGenomics Inc.
World Rank (Aug-2026)
6,256
Market Cap (Aug-2026)
2.048 Billion USD
World Rank (Jan-05-2024)
5,578
Market Cap (Jan-05-2024)
2.053 Billion USD
World Rank (Jul-30-2023)
5,407
Market Cap (Jul-30-2023)
2.202 Billion USD
World Rank (Dec-25-2022)
7,690
Market Cap (Dec-25-2022)
1.158 Billion USD
World Rank (Jan-07-2022)
4,374
Market Cap (Jan-07-2022)
3.45 Billion USD
Annual Revenue in USD
727 Million USD
Annual Net Income in USD
-108 Million USD
Annual Results for Period Ending
For year ending December-2025
Company Profile
NeoGenomics is a Premier Cancer Diagnostics and Pharma Services company. It is a serving oncologists, pathologists, pharmaceutical companies, academic centers and others with innovative diagnostic, prognostic and predictive testing. The company support clients in many cancer related market segments including hospital and private pathology laboratories, office based oncologists, academic institutions, contract research and pharmaceutical development organizations. The headquarters is in USA.
Company Website